Verition Fund Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $2.07M | Buy |
|
|||||
|
2025
Q1 | $1.06M | Buy |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $177K | Buy |
|
|||||
|
2022
Q4 | $159K | Sell |
|
|||||
|
2022
Q3 | $148K | Sell |
|
|||||
|
2022
Q2 | $687K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $264K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $119K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $396K | Buy |
|
|||||
|
2019
Q3 | $232K | Buy |
|
|||||
|
2019
Q2 | $197K | Sell |
|
|||||
|
2019
Q1 | $1.54M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.44M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $195K | Sell |
|
|||||
|
2017
Q3 | $1.27M | Sell |
|
|||||
|
2017
Q2 | $2.41M | Sell |
|
|||||
|
2017
Q1 | $3.18M | Buy |
|
|||||
|
2016
Q4 | $861K | Sell |
|
|||||
|
2016
Q3 | $1.7M | Buy |
|
|||||
|
2016
Q2 | $1.48M | Buy |
|
|||||
|
2016
Q1 | $666K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $536K | Buy |
|